Literature DB >> 11544024

Adhesion events in angiogenesis.

B P Eliceiri1, D A Cheresh.   

Abstract

Recent work from several laboratories indicates that the coordination of endothelial cell adhesion events with growth factor receptor inputs regulates endothelial cell responses during angiogenesis. Analyses of the signaling pathways downstream of integrins, cadherins and growth-factor receptors are providing an insight into the molecular basis of known anti-angiogenic strategies, as well as into the design of novel therapies.

Mesh：

Substances：

Year:  2001        PMID： 11544024     DOI： 10.1016/s0955-0674(00)00252-0

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN： 0955-0674            Impact factor:   8.382


  55 in total

1.  Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation.

Authors:  Sharon Klein; Antonin R de Fougerolles; Pamela Blaikie; Leila Khan; Angela Pepe; Cynthia D Green; Victor Koteliansky; Filippo G Giancotti
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

2.  New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

Authors:  Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

Review 3.  Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods.

Authors:  Markus Rudin; Martin Rausch; Markus Stoeckli
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

4.  The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

Authors:  Athanasios N Athanasopoulos; Matina Economopoulou; Valeria V Orlova; Astrid Sobke; Darius Schneider; Holger Weber; Hellmut G Augustin; Sabine A Eming; Uwe Schubert; Thomas Linn; Peter P Nawroth; Muzaffar Hussain; Hans-Peter Hammes; Mathias Herrmann; Klaus T Preissner; Triantafyllos Chavakis
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

5.  HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.

Authors:  Elena Toschi; Ilaria Bacigalupo; Raffaele Strippoli; Chiara Chiozzini; Anna Cereseto; Mario Falchi; Filomena Nappi; Cecilia Sgadari; Giovanni Barillari; Fabrizio Mainiero; Barbara Ensoli
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

6.  Expression of integrins in human proliferative diabetic retinopathy membranes.

Authors:  Allison Ning; Jing Cui; David Maberley; Patrick Ma; Joanne Matsubara
Journal:  Can J Ophthalmol       Date:  2008-12       Impact factor: 1.882

7.  Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression.

Authors:  Longxuan Li; Jennifer V Welser; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

8.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression.

Authors:  Cheng-Hung Chou; Yi-Fang Cheng; Tiing Yee Siow; Amit Kumar; Konan Peck; Chen Chang
Journal:  Clin Exp Metastasis       Date:  2013-02-19       Impact factor: 5.150

10.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.